Prospective Observational Study on the Analgesic Effectiveness of Blocking the Suprascapular and Axillary Nerves in Shoulder Arthroscopy.
Launched by JOSE MANUEL LÓPEZ GONZÁLEZ · Sep 22, 2024
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
An observational study of paired cohorts, not randomized, was designed with the aim of comparing the postoperative analgesic effectiveness of two regional analgesic techniques: the shoulder anterior capsular block associated with the suprascapular nerve block performed via an anterior approach versus the suprascapular and axillary nerve blocks performed posteriorly in patients with shoulder surgery via arthroscopy in procedures that cause intense postoperative pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 18 years of age.
- • ASA (Physical Status Classification System) I - III.
- • Having been scheduled for shoulder arthroscopy surgery.
- Exclusion Criteria:
- Any contraindication for performing regional anesthetic techniques:
- • Infection at the puncture point.
- • Alteration of hemostasis.
- • Allergy to local anesthetics.
- • Patient refusal to participate in the study.
- • Inability to evaluate postoperative pain.
- • Known neuropathy of the operated limb.
- • Patients who required conversion to open surgery.
About Jose Manuel López González
Jose Manuel López González is a dedicated clinical trial sponsor with extensive expertise in the management and oversight of clinical research initiatives. With a strong commitment to advancing medical knowledge and improving patient outcomes, he leads multifaceted trials that adhere to the highest standards of regulatory compliance and ethical considerations. His collaborative approach fosters partnerships with healthcare professionals, research institutions, and regulatory bodies, ensuring the successful execution of trials across various therapeutic areas. Through innovative methodologies and a focus on patient-centered care, José Manuel López González aims to contribute to the development of safe and effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oviedo, Asturias, Spain
Patients applied
Trial Officials
Bárbara María Jiménez Gómez, MD
Principal Investigator
Central University Hospital of Asturias, 33001, Spain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported